Latest Information
Brain Navi Biotechnology has officially entered the Spanish market, completing its first NaoTrac-assisted neurosurgeries in collaboration with Palex Healthcare. The launch followed strong interest from surgeons during the SENEC Congress, where NaoTrac was showcased as an AI-powered navigation solution. Palex leaders emphasized Spain’s potential in neurosurgical innovation and their shared vision with Brain Navi to improve surgical precision and patient outcomes. This milestone marks a key step in Brain Navi’s
Cottbus, Germany – The first surgeries with the neurosurgical navigation robot NaoTrac have now been successfully started at the Medizinische Universität Lausitz – Carl Thiem.
Brain Navi Biotechnology has officially received U.S. FDA 510(k) clearance for its neurosurgical robot NaoTrac, now classified as a "Stereotaxic Guiding Surgical Device." Following earlier approvals from Taiwan’s TFDA and the European CE Mark, this milestone reinforces NaoTrac’s international recognition in safety and clinical effectiveness. Designed to assist with various neurosurgical procedures, NaoTrac integrates AI-powered autonomous navigation and robotic precision to support safer, more efficient surgeries in the operating room.
Dr. Hao-Yu Chuang's team used NaoTrac for stereotactic brain surgeries, achieving high accuracy in tumor biopsies and ICH drainage. The results were recognized at AANS.
Cottbus, Germany – The first surgeries with the neurosurgical navigation robot NaoTrac have now been successfully started at the Medizinische Universität Lausitz – Carl Thiem.
Brain Navi Biotechnology has officially received U.S. FDA 510(k) clearance for its neurosurgical robot NaoTrac, now classified as a "Stereotaxic Guiding Surgical Device." Following earlier approvals from Taiwan’s TFDA and the European CE Mark, this milestone reinforces NaoTrac’s international recognition in safety and clinical effectiveness. Designed to assist with various neurosurgical procedures, NaoTrac integrates AI-powered autonomous navigation and robotic precision to support safer, more efficient surgeries in the operating room.
The article primarily shares the experiences of neurosurgeons in Bolivia, Latin America, regarding their use of NaoTrac and the publication of their findings.
Brain Navi Biotechnology has officially entered the Spanish market, completing its first NaoTrac-assisted neurosurgeries in collaboration with Palex Healthcare. The launch followed strong interest from surgeons during the SENEC Congress, where NaoTrac was showcased as an AI-powered navigation solution. Palex leaders emphasized Spain’s potential in neurosurgical innovation and their shared vision with Brain Navi to improve surgical precision and patient outcomes. This milestone marks a key step in Brain Navi’s global expansion across Europe.
In collaboration with Palex Healthcare, we introduce NaoTrac, the advanced neurosurgical navigation robot enhancing precision and safety. Join us in SENEC as we support innovation and excellence in Spanish neurosurgery.
Dr. Hao-Yu Chuang's team used NaoTrac for stereotactic brain surgeries, achieving high accuracy in tumor biopsies and ICH drainage. The results were recognized at AANS.
NaoTrac, the AI-driven autonomous neurosurgical navigation robot, enhances surgical precision and efficiency. Powered by Avalue Healthcare’s Medical Edge AI PC MAB-T600, it enables real-time 3D imaging, robotic-assisted navigation, and AI-driven machine vision. With nearly 160 successful surgeries, this collaboration is setting new standards in neurosurgery.
NaoTrac in Prone Position
